{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:46:59Z","timestamp":1776030419058,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Clinical Oncology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple cancers occur in the same individual, such as hereditary breast and ovarian cancer (HBOC) syndrome and Lynch syndrome. Here, we report a patient with HBOC syndrome who developed four different cancer types (pancreatic cancer, right lung adenocarcinoma, prostate cancer, and left lung adenocarcinoma) within a relatively short period of 6.5\u00a0years. In HBOC syndrome, the lung adenocarcinoma is rare, and the tumors were initially suspected to be lung metastases from pancreatic cancer, respectively. The pathological analysis results in each of the three lesions were inconsistent. A whole-exome analysis was performed on all three tumors using next-generation sequencing (NGS). The results showed that many of the deletion mutations found in pancreatic cancer were not present in other lung tumors. Homologous recombination is required for the repair of deletion mutations, but this function is impaired in HBOC syndrome. Deletions occurring in the primary tumor are irreversible and should be inherited in metastatic lesions. Therefore, we hypothesized that these three cancers arose independently, that each lung tumor was a primary tumor rather than a metastasis of pancreatic cancer, and that their resection would be curative. This assumption was reasonable, as no new lesions were observed in a 10-year follow-up study since the onset of pancreatic cancer. Tracking genetic traits using NGS helps understand the origins and progression of malignant tumors.<\/jats:p>","DOI":"10.1093\/jjco\/hyaf222","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T12:28:00Z","timestamp":1767443280000},"page":"489-495","source":"Crossref","is-referenced-by-count":0,"title":["Role of clonal lineage analysis via next-generation sequencing in identifying the origin of multiple cancers and guiding treatment options"],"prefix":"10.1093","volume":"56","author":[{"given":"Rie","family":"Shimoyachi","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Shimazu","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Akita City Hospital , Kawamotomatsuoka-machi 4-30, 010-0933 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Akita University Graduate School of Medicine , Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nanjyo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akita University Hospital , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-3506","authenticated-orcid":false,"given":"Hiroyuki","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Akita University , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]},{"name":"Center for Cancer Registry and Information Services, Akita University Hospital , Hondo1-1-1, Akita 010-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2026041217381330200_ref1","doi-asserted-by":"publisher","DOI":"10.1177\/11795476221150597","article-title":"One patient with 4 different primary cancers: a case report","volume":"16","author":"Nguyen","year":"2023","journal-title":"Clin Med Insights Case Rep"},{"key":"2026041217381330200_ref2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4274\/tjcd.galenos.2021.2021-9-4","article-title":"A rare multiple primary cancer: a case report of quadruple primary cancer","volume":"32","author":"\u015eenol","year":"2022","journal-title":"Turk J Colorectal Dis"},{"key":"2026041217381330200_ref3","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"2026041217381330200_ref4","volume-title":"GeneReviews\u00ae","author":"Petrucelli","year":"1993\u20132025"},{"key":"2026041217381330200_ref5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026041217381330200_ref6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA","volume":"8","author":"Momozawa","year":"2022","journal-title":"Oncology"},{"key":"2026041217381330200_ref7","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","article-title":"Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer","volume":"31","author":"Castro","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026041217381330200_ref8","first-page":"997","article-title":"Next-generation sequencing technology: current trends and advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biology (Basel)"},{"key":"2026041217381330200_ref9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2026041217381330200_ref10","doi-asserted-by":"publisher","first-page":"e70443","DOI":"10.1002\/cam4.70443","article-title":"Regional differences in the frequency of BRCA1 and BRCA2 variants in Northeastern Japan: a cohort study","volume":"14","author":"Shirota","year":"2025","journal-title":"Cancer Med"},{"key":"2026041217381330200_ref11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cjp2.271","article-title":"Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types","volume":"8","author":"Budczies","year":"2022","journal-title":"J Pathol Clin Res"},{"key":"2026041217381330200_ref12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41698-024-00672-0","article-title":"The intersection of HR and mismatch repair (MMR) pathways in DNA repair-defective tumors","volume":"8","author":"Incorvaia","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026041217381330200_ref13","doi-asserted-by":"publisher","first-page":"588557","DOI":"10.3389\/fonc.2020.588557","article-title":"Intratumor heterogeneity of MYO18A and FBXW7 variants impact the clinical outcome of stage III colorectal cancer","volume":"10","author":"Lin","year":"2020","journal-title":"Front Oncol"},{"key":"2026041217381330200_ref14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13059-019-1867-0","article-title":"Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents","volume":"20","author":"P\u00f3ti","year":"2019","journal-title":"Genome Biol"},{"key":"2026041217381330200_ref15","author":"Clinvar database"},{"key":"2026041217381330200_ref16","author":"jMorp database"},{"key":"2026041217381330200_ref17","author":"The Breast Cancer Information Core database"},{"key":"2026041217381330200_ref18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"2026041217381330200_ref19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13053-021-00174-1","article-title":"Characteristics of BRCA1\/2 pathogenic germline mutations in Chinese NSCLC patients and a comparison with HBOC","volume":"19","author":"Xu","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"key":"2026041217381330200_ref20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12253-019-00771-5","article-title":"Spectrum of pathogenic germline mutations in Chinese lung cancer patients through next-generation sequencing","volume":"26","author":"Tian","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"2026041217381330200_ref21","first-page":"100068","article-title":"Somatic and germline BRCA 1 and 2 mutations in advanced NSCLC from the SAFIR02-lung trial","volume":"1","author":"Remon","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"2026041217381330200_ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e13007","article-title":"BRCA1\/2 germline mutations and response to PARP inhibitor treatment in lung cancer. Meeting Abstract: 2019 ASCO Annual Meeting I, Publication","volume":"37","author":"Fang","journal-title":"J Clin Oncol"},{"key":"2026041217381330200_ref23","doi-asserted-by":"publisher","first-page":"e2300190","DOI":"10.1200\/PO.23.00190","article-title":"Rate of pathogenic germline variants in patients with lung cancer","volume":"7","author":"Sorscher","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"2026041217381330200_ref24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamaoncol.2025.2879","article-title":"Established cancer predisposition genes in single and multiple cancer diagnoses","volume":"11","author":"Shevach","year":"2025","journal-title":"JAMA Oncol"},{"key":"2026041217381330200_ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e20054"},{"key":"2026041217381330200_ref26","doi-asserted-by":"publisher","first-page":"e70990","DOI":"10.1002\/cam4.70990","article-title":"Estimating cancer penetrance in carriers of BRCA2 pathogenic variants using cancer-specific polygenic scores","volume":"14","author":"Prassas","year":"2025","journal-title":"Cancer Med"},{"key":"2026041217381330200_ref27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJMe0903044","article-title":"Synthetic lethality\u2014a new direction in cancer-drug development","volume":"361","author":"Iglehart","year":"2009","journal-title":"N Engl J Med"},{"key":"2026041217381330200_ref28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenanceolaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/4\/489\/66556471\/hyaf222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/4\/489\/66556471\/hyaf222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:38:20Z","timestamp":1776029900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/4\/489\/8439472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,1,23]]},"published-print":{"date-parts":[[2026,4,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf222","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,23]]}}}